Detalles de la búsqueda
1.
Antiarrhythmic effect of the Ca2+-activated K+ (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation.
Pflugers Arch
; 468(11-12): 1853-1863, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27722784
2.
pH-dependent inhibition of K2P3.1 prolongs atrial refractoriness in whole hearts.
Pflugers Arch
; 468(4): 643-54, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729267
3.
The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs.
Front Pharmacol
; 11: 159, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32180722
4.
Inhibition of KCa2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia.
Front Pharmacol
; 11: 749, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32508659
5.
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man.
Front Pharmacol
; 11: 610, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32477117
6.
The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts.
Front Pharmacol
; 10: 668, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31275147
7.
A new negative allosteric modulator, AP14145, for the study of small conductance calcium-activated potassium (KCa 2) channels.
Br J Pharmacol
; 174(23): 4396-4408, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28925012
Resultados
1 -
7
de 7
1
Próxima >
>>